Rafferty Asset Management, LLC Mirati Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$41.99 - $62.38 $3.81 Million - $5.66 Million	-90,681 Reduced 36.33%	158,931 $9.34 Million
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $861,049 - $1.4 Million	30,973 Added 14.17%	249,612 $10.9 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $1.63 Million - $2.23 Million	45,123 Added 26.01%	218,639 $7.9 Million
Q1 2023 May 11, 2023	SELL	$36.54 - $54.26 $714,612 - $1.06 Million	-19,557 Reduced 10.13%	173,516 $6.45 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $4.6 Million - $11 Million	111,361 Added 136.28%	193,073 $8.75 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $1.01 Million - $1.48 Million	17,048 Added 26.36%	81,712 $5.71 Million
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $60,188 - $136,347	-1,537 Reduced 2.32%	64,664 $4.34 Million
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $2.05 Million - $4.09 Million	27,070 Added 69.18%	66,201 $5.44 Million
Q4 2021 Feb 10, 2022	BUY	$132.01 - $190.29 $2.68 Million - $3.87 Million	20,312 Added 107.93%	39,131 $5.74 Million
Q3 2021 Nov 10, 2021	BUY	$132.13 - $177.45 $483,331 - $649,112	3,658 Added 24.13%	18,819 $3.33 Million
Q2 2021 Aug 10, 2021	SELL	$144.0 - $179.73 $341,856 - $426,679	-2,374 Reduced 13.54%	15,161 $2.45 Million
Q1 2021 May 10, 2021	BUY	$158.92 - $221.61 $2.16 Million - $3.02 Million	13,623 Added 348.24%	17,535 $3 Million
Q4 2020 Feb 10, 2021	SELL	$162.05 - $240.27 $1.8 Million - $2.67 Million	-11,109 Reduced 73.96%	3,912 $859,000
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $645,582 - $953,439	5,700 Added 61.15%	15,021 $2.49 Million
Q2 2020 Aug 07, 2020	BUY	$72.01 - $120.39 $374,956 - $626,870	5,207 Added 126.57%	9,321 $1.06 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $2.15 Million - $3.58 Million	-30,837 Reduced 88.23%	4,114 $316,000
Q4 2019 Feb 10, 2020	SELL	$70.76 - $128.86 $2.89 Million - $5.26 Million	-40,816 Reduced 53.87%	34,951 $4.5 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $1.82 Million - $2.56 Million	23,314 Added 44.45%	75,767 $5.9 Million
Q2 2019 Aug 09, 2019	SELL	$59.49 - $104.71 $1.13 Million - $1.99 Million	-19,043 Reduced 26.64%	52,453 $5.4 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $3.12 Million - $5.64 Million	71,496 New	71,496 $5.24 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account